ReviewAnalysis of estrogens in serum and plasma from postmenopausal women: Past present, and future
Introduction
17β-Estradiol (estradiol) induces tumors in animal models and in humans and elevated estrogen levels in postmenopausal women are associated with increased breast cancer risk [1]. This is thought to arise from a dual mechanism in which estradiol can act either as a hormone to stimulate aberrant cell proliferation or as the precursor to the formation of genotoxic metabolites [2]. Estrogen biosynthesis which occurs in the breast tissue of postmenopausal women is fundamentally different from that which occurs in the ovaries of premenopausal women. Unlike the ovaries, breast tissue lacks the ability to synthesize androgen precursors. Hence, estrogen production is dependent upon the availability of circulating C-19 androgen precursors and local conversion to estrogens in target tissues such as the breast. The estrogens can then be released into the circulation, which provides biomarkers of tissue estrogen biosynthesis.
Investigative studies and new therapies have significantly improved the recurrence-free and overall survival rates in breast cancer patients [3]. However, the ability to prevent breast cancer in the first place is a much more desirable goal, particularly as the world population is aging and age is an important determinant of breast cancer risk [4], [5]. This requires the selection of women who are at higher breast cancer risk for treatment with chemoprevention agents because previous studies have shown that this approach leads to an enhanced benefit/risk ratio [6], [7]. Further implementation of this strategy will require the development of new models to predict breast cancer risk of particular individuals [8]. Postmenopausal women with elevated plasma or serum estrogens are at increased risk for breast cancer [4], [9], [10], [11], [12], [13]. Unfortunately, much of the current bioanalytical methodology employed for the analysis of plasma or serum estrogens has proved to be problematic [14], [15]. Major advances in risk assessment would be possible if more reliable methodology were readily available to quantify estradiol and its major metabolites in the plasma or serum of postmenopausal women [4]. These measurements could then be coupled with other risk factors such as mammographic density [16], bone density [17], BMI [18], and single-nucleotide polymorphisms associated with breast cancer [19] to provide an improved model of breast cancer risk [6]. In addition, the availability of sensitive and specific plasma or serum estrogen assays would make it possible to more reliably assess the effects of aromatase inhibitors in postmenopausal women [20]. The present review will focus on the enzymes involved in estrogen biosynthesis, the biological effects of different estrogen metabolites, and the analysis of total (free and non-covalently bound) forms of estradiol and its metabolites in plasma and serum.
Section snippets
Enzymology of estrogen biosynthesis in postmenopausal women
The adrenal cortex is the principal source of C19 androgens, dehydroepiandrosterone (DHEA) and androstenedione (Fig. 1). Cholesterol is first metabolized to pregnenolone by cytochrome P-450 (CYP) 11A1, the side-chain cleavage enzyme [21]. Pregnenolone is then metabolized to progesterone through the action of 3β-hydroxysteroid dehydrogenase (HSD) or to 17α-hydroxy-pregnenolone by CYP17A. 17α-hydroxy-pregnenolone is further metabolized to 17α-hydroxy-progesterone by 3β-HSD.
Estradiol metabolism
Estradiol is metabolized to a 3-glucuronide by UGT1A1 [42] and to a 17β-glucuronide by UGT1A3 and 2B7 (Fig. 2) [43], [44]. It is metabolized to estradiol-3-sulfate by SULT1A1 [45], [46], SULT1E1 [46], [47], and SULT2A1 [48]. Estradiol-17β-sulfate was also observed as a minor metabolite in SULT2A1-mediated estradiol metabolism (Fig. 2). Tissue steroid sulfatase can convert estradiol-3-sulfate back to estradiol [49]. Therefore, in menopausal women, circulating estradiol-3-sulfate can serve as a
Estrone metabolism
Estrone is metabolized to a 3-glucuronide by UGT1A8 [44] and to a 3-sulfate at high concentrations by SULT1A1 and at low concentrations by SULT1E1 (Fig. 3) [74]. Estrone also undergoes extrahepatic oxidation by CYP1A1 and hepatic oxidation by CYP1A2 and CYP3A in a similar manner to estradiol to give the catechol derivatives, 2-hydroxy-estrone and 4-hydroxy-estrone (Fig. 3) [50]. In contrast, CYP1B1, metabolizes estrone to 4-hydroxy-estrone with relatively high regioselectivity [56].
Quantitative analysis of estrogens in the plasma and serum of postmenopausal women
Estradiol and its metabolites are present in plasma and serum in the free unbound form, non-covalently bound to steroid binding proteins, and as glucuronide and sulfate conjugates. Concentrations of the free (unbound) forms of plasma and serum estrogens in postmenopausal women are in the fg/mL range, which puts them below the limit of quantitation (LOQ) of routine assays [89], [90]. The LOQ is defined as the lowest concentration of an analyte in a sample that can be quantitatively determined
Future directions
The three derivatization strategies described above make it possible to quantify plasma and serum estrogens with LOQs in the low pg/mL (pmol/L) range (Table 1) [97], [114], [115], [116], [117], [120]. The availability of methodology based on these novel ionization techniques coupled with GC–MS/MS or LC–MS/MS will greatly facilitate future studies to rigorously establish the precise levels of individual estrogens that are present in the plasma of postmenopausal women.
The ESI process requires
Acknowledgements
I acknowledge the support of NIH grants UO1ES16004 and P30ES013508 and helpful discussions with Dr. Richard Santen of the University of Virginia and Dr. Trevor Penning of the University of Pennsylvania.
References (123)
- et al.
Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer
Ann Oncol
(2009) - et al.
Chemoprevention of breast cancer for women at high risk
Semin Oncol
(2006) - et al.
The role of local estrogen biosynthesis in males and females
Trends Endocrinol Metab
(2000) - et al.
Structure/function aspects of human 3beta-hydroxysteroid dehydrogenase
Mol Cell Endocrinol
(2004) - et al.
A guide to 17beta-hydroxysteroid dehydrogenases
Mol Cell Endocrinol
(2001) Molecular genetics of androgenic 17 beta-hydroxysteroid dehydrogenases
J Steroid Biochem Mol Biol
(1995)- et al.
Analysis of 17beta-hydroxysteroid dehydrogenase types 5, 7, and 12 genetic sequence variants in breast cancer cases from French Canadian Families with high risk of breast and ovarian cancer
J Steroid Biochem Mol Biol
(2009) - et al.
Structure-function of human 3 alpha-hydroxysteroid dehydrogenases: genes and proteins
Mol Cell Endocrinol
(2004) - et al.
Expression of aromatase and 17beta-hydroxysteroid dehydrogenase types 1, 7 and 12 in breast cancer. An immunocytochemical study
J Steroid Biochem Mol Biol
(2006) 17Beta-hydroxysteroid dehydrogenase enzymes and breast cancer
J Steroid Biochem Mol Biol
(2009)
17beta-hydroxysteroid dehydrogenase type 7—an ancient 3-ketosteroid reductase of cholesterogenesis
Mol Cell Endocrinol
Structure and function of 17beta-hydroxysteroid dehydrogenase type 1 and type 2
Mol Cell Endocrinol
Intracrinology of estrogens and androgens in breast carcinoma
J Steroid Biochem Mol Biol
Differential glucuronidation of bile acids, androgens and estrogens by human UGT1A3 and 2B7
J Steroid Biochem Mol Biol
Catecholestrogen sulfation: possible role in carcinogenesis
Biochem Biophys Res Commun
Sulfotransferase 2A1 forms estradiol-17-sulfate and celecoxib switches the dominant product from estradiol-3-sulfate to estradiol-17-sulfate
J Steroid Biochem Mol Biol
Role of steroid sulfatase in local formation of estrogen in post-menopausal breast cancer patients
J Steroid Biochem Mol Biol
Cytochrome P450-mediated metabolism of estrogens and its regulation in human
Cancer Lett
4-Hydroxy estradiol but not 2-hydroxy estradiol induces expression of hypoxia-inducible factor 1alpha and vascular endothelial growth factor A through phosphatidylinositol 3-kinase/Akt/FRAP pathway in OVCAR-3 and A2780-CP70 human ovarian carcinoma cells
Toxicol Appl Pharmacol
Glucuronidation of catechol estrogens by expressed human UDP-glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7
Toxicol Sci
The impact of endogenous estradiol metabolites on carcinogenesis
Steroids
Expression of UGT2B7, a UDP-glucuronosyltransferase implicated in the metabolism of 4-hydroxyestrone and all-trans retinoic acid, in normal human breast parenchyma and in invasive and in situ breast cancers
Am J Pathol
Role of DNA adducts in hormonal carcinogenesis
Regul Toxicol Pharmacol
Limitations of direct estradiol and testosterone immunoassay kits
Steroids
Some new aspects of 17alpha-estradiol metabolism in man
Steroids
Potential role of ultra-sensitive estradiol assays in estimating the risk of breast cancer and fractures
Steroids
Superiority of gas chromatography/tandem mass spectrometry assay (GC/MS/MS) for estradiol for monitoring of aromatase inhibitor therapy
Steroids
Is estradiol a genotoxic mutagenic carcinogen?
Endocr Rev
Genotoxicity of the steroidal oestrogens oestrone and oestradiol: possible mechanism of uterine and mammary cancer development
Hum Reprod Update
Assessing individual risk for breast cancer: role of oestrogens and androgens
Breast Cancer Res
Hormones and breast cancer
Hum Reprod Update
Critical assessment of new risk factors for breast cancer: considerations for development of an improved risk prediction model
Endocr Relat Cancer
A breast cancer prediction model incorporating familial and personal risk factors
Stat Med
Relation of prediagnostic serum estrogen and androgen levels to breast cancer risk
Cancer Epidemiol Biomarkers Prevent
Serum sex hormones and breast cancer risk factors in postmenopausal women
Cancer Epidemiol Biomarkers Prevent
Postmenopausal serum androgens, oestrogens and breast cancer risk: the European prospective investigation into cancer and nutrition
Endocr Relat Cancer
Circulating 2-hydroxy- and 16alpha-hydroxy estrone levels and risk of breast cancer among postmenopausal women
Cancer Epidemiol Biomarkers Prevent
Circulating estrogen metabolites and risk for breast cancer in premenopausal women
Cancer Epidemiol Biomarkers Prevent
Deficits in plasma oestradiol measurement in studies and management of breast cancer
Breast Cancer Res
Standardization of steroid hormone assays: why, how, and when?
Cancer Epidemiol Biomarkers Prevent
Mammographic density and breast cancer risk: evaluation of a novel method of measuring breast tissue volumes
Cancer Epidemiol Biomarkers Prevent
Hip bone density predicts breast cancer risk independently of Gail score: results from the Women's Health Initiative
Cancer
Minireview: obesity and breast cancer: the estrogen connection
Endocrinology
Value of adding single-nucleotide polymorphism genotypes to a breast cancer risk model
J Natl Cancer Inst
History of aromatase: saga of an important biological mediator and therapeutic target
Endocr Rev
Expression of enzymes involved in synthesis and metabolism of estradiol in human breast as studied by immunocytochemistry and in situ hybridization
Histol Histopathol
Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones
Biochem J
Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells
Cancer Res
15-Oxo-eicosatetraenoic acid, a metabolite of macrophage 15-hydroxyprostaglandin dehydrogenase that inhibits endothelial cell proliferation
Mol Pharm
Structural and biochemical characterization of human orphan DHRS10 reveals a novel cytosolic enzyme with steroid dehydrogenase activity
Biochem J
Cited by (100)
Pre-breeding androgen and glucocorticoid profiles in the eastern hellbender salamander (Cryptobranchus alleganiensis alleganiensis)
2021, General and Comparative EndocrinologyAdvancements in the gold standard: Measuring steroid sex hormones by mass spectrometry
2020, Clinical BiochemistryParallel derivatization strategy coupled with liquid chromatography-mass spectrometry for broad coverage of steroid hormones
2020, Journal of Chromatography ACitation Excerpt :Steroid hormones are of exceptional importance to human body, and they act as signaling molecules in various physiological processes including the regulation of transcription, the maintenance of secondary sexual characteristics and the mediation of the immune and endocrine systems. Recently, multiple studies have demonstrated that the metabolism disorder of steroid hormones in the human body is closely related to numerous diseases such as cardiovascular disease, endocrine disorders [1], prostate cancer [2], breast cancer [3] and endometrial cancer [4]. A highly sensitive, stable and reliable analytical method enabling to achieve quantitative profiling of steroid hormones is of great significance for studying the pathogenesis of these diseases.